Market Place
Sourcing Support
Nanopharmaceutics, Northwestern Initiate Oral Triapine+TMZ Recurrent GBM Study
14 May 2024 //
PR NEWSWIRE
ORPHELIA Pharma Selects Tanner Pharma Group to Initiate Named Patient Program
18 Apr 2023 //
BUSINESSWIRE
NPPA revises ceiling prices of 128 formulations
17 Jan 2023 //
ECONOMIC TIMES
Merck Enters Collaboration with Nerviano to Develop PARP1 Selective Inhibitor
22 Sep 2022 //
BUSINESSWIRE
OncXerna`s Upcoming ASCO Poster Featuring Data of PII Glioblastoma Trial
03 Jun 2022 //
GLOBENEWSWIRE
Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival
24 Mar 2022 //
BUSINESSWIRE
EpicentRx begins Phase I trial of paediatric CNS tumour treatment
25 Feb 2022 //
CLINICALTRIALSARENA
Novocure announces National reimbursement in Switzerland for Optune
15 Dec 2020 //
PHARMABIZ
Novocure Announces National Reimbursement in Switzerland for Optune®
14 Dec 2020 //
BUSINESSWIRE
Novocure Announces National Reimbursement in Switzerland for Optune®
14 Dec 2020 //
BUSINESSWIRE
Pelareorep-based combination therapy improves glioblastoma patient survival
24 Nov 2020 //
EUROPEANPHARMACEUTICALREVIEW
TRACON Announces Publication in Cancer Cell of Clinical Data Molecular Insight
23 Nov 2020 //
GLOBENEWSWIRE
Tert Promoter Mutations May Not Be Indicative Of Sensitivity To Temozolomide
20 Sep 2020 //
ESMO
Denovo Biopharma Receives FDA`s Permission to Proceed with a Biomarker
15 Oct 2019 //
PRNEWSWIRE
Bristol-Myers Squibb`s Opdivo Shows 5-Year Survival Benefit in Lung Cancer
11 Sep 2019 //
BIOSPACE
FDA Warns Turkish Drugmaker Over Penicillin Cross-Contamination Issues
20 Aug 2019 //
RAPS
Enforcement Report - Week of July 31, 2019
31 Jul 2019 //
FDA
DEVA HOLDING A.S. on FDA Import Alert List
01 Jul 2019 //
FDA
DelMar Provides Clinical Update on VAL-083
04 Jun 2019 //
PR NEWSWIRE
Adastra Pharmaceuticals Positive Interim Data for Phase 1b Trial of Zotiraciclib
04 Jun 2019 //
PR NEWSWIRE
Enforcement Report - Week of February 27, 2019
27 Feb 2019 //
FDA
Enforcement Report - Week of January 2, 2019
02 Jan 2019 //
FDA
Enforcement Report - Week of October 24, 2018
24 Oct 2018 //
FDA
JIANGSU YEW Pharmaceutical Co. Ltd. Fails EDQM Inspection
15 Sep 2018 //
EDQM
Novocure & Zai Lab Announce License Agreement in Greater China
13 Sep 2018 //
BUSINESSWIRE
Could even more cancer patients benefit from PARP inhibitors?
16 Jul 2018 //
FIERCE BIOTECH
Apotex Inc.’s Generic Temozolomide Receives Approval In The US
09 Jul 2018 //
FDA
Come-from-behind Sanofi aims for third in lung cancer
15 Jun 2018 //
FIERCE PHARMA
Enforcement Report - Week of May 16, 2018
16 May 2018 //
FDA
Zydus Pharm’s Generic Temozolomide Receives Approval In US
01 Aug 2017 //
FDA
Deva Holding AS Generics Temozolomide Receives Approval In US
28 Apr 2017 //
FDA
GW Pharma`s Cannabis-Derived Drug Shows Promise in Brain Cancer Study
08 Feb 2017 //
DDDMAG
Mylan Recalling Brain Tumor Drug
27 Jan 2017 //
FIERCE PHARMA
Tocagen begins enrolling patients in Toca 5 phase 2/3 trial in South Korea
16 Jan 2017 //
PHARMABIZ
AbbVie’s ph2 PARP study misses survival endpoints; hopes rest on bigger phase 3
07 Dec 2016 //
FIERCE BIOTECH
Chemi`s Generic Temozolomide Receives Approval In US
23 Nov 2016 //
FDA
List Of Drugs Approved By Anvisa
03 Oct 2016 //
ANVISA
AMERIGEN announces final approval from FDA for generic version of Temodar®
18 Aug 2016 //
PR NEWSWIRE
Mylan Launches Generic Temodar® Capsules
11 Jul 2016 //
PR NEWSWIRE
Lotus Pharm`s Temozolomide approved in US an anti-cancer chemotherapy drug
27 Apr 2016 //
FDA
IDT Australia Ltd`s Generic Temozolomide approved in US as chemotherapy drug
12 Apr 2016 //
FDA
DelMar to Present Updated PhII Safety and Efficacy Data on VAL-083
09 Nov 2015 //
PR NEWS WIRE
Merck recalls 276,000 pill bottles
21 Aug 2015 //
IN-PHARMA TECHNOLOGIST
Celldex Builds Case for Brain Cancer Vaccine With New ASCO Data
31 May 2015 //
XCONOMY
12 cancer drugs may come under price control
05 May 2015 //
THE INDIAN EXPRESS
DelMar Pharmaceuticals Receives Notice of Allowance for Third US Patent for VAL-083
13 Jan 2015 //
DELMAR PHARMACEUTICALS
